Literature DB >> 18570975

Human herpesvirus 8 infections in patients with immunodeficiencies.

Camille Laurent1, Fabienne Meggetto, Pierre Brousset.   

Abstract

In 1994, Chang et al described a novel herpesvirus in tissues from patients with Kaposi sarcoma, referred to as Kaposi sarcoma herpesvirus or human herpesvirus 8. They used a very sophisticated technique of molecular biology to isolate unknown DNA sequences from Kaposi sarcoma lesions, which were not present in normal tissues. It turned out that these sequences corresponded to a previously unrecognized gamma herpesvirus highly homologous to human herpesvirus 4 (Epstein-Barr virus) and to herpesvirus saimiri. Contrary to Epstein-Barr virus, human herpesvirus 8 is not ubiquitous. The seroprevalence of human herpesvirus 8 varies greatly worldwide, with 1% to 10% of people being infected in developed countries and up to 80% of infected individuals in some areas of sub-Saharan and equatorial Africa. Human herpesvirus 8 is associated with a limited spectrum of tumors, mostly observed in immunodeficient individuals with HIV infection. Beside Kaposi sarcoma and multicentric Castleman disease, human herpesvirus 8 is associated with primary effusion lymphoma, but unlike Epstein-Barr virus, human herpesvirus 8 is not involved in epithelial tumors. Different proteins of the virus can be detected in infected cells. Antibodies against the latent nuclear antigen 1 are available in routine pathology and represent a powerful tool to detect the virus in human tissues. Although Epstein-Barr virus is the most frequent causative agent of lymphomas in immunocompromised individuals, a systematic screening of such tumors with specific antibodies reveals that the implication of human herpesvirus 8 infection is probably underestimated. Recent descriptions of non-Hodgkin lymphoma in endemic areas, solid localizations of primary effusion lymphoma, and posttransplantation lymphoproliferations have expanded the spectrum of human herpesvirus 8-related lymphoproliferative disorders. In this review, we will be presenting an overview of the recent concepts regarding human herpesvirus 8 and related disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570975     DOI: 10.1016/j.humpath.2008.02.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.

Authors:  Paolo Nicoli; Ubaldo Familiari; Marco Bosa; Tiziano Allice; Francesca Mete; Alessandro Morotti; Daniela Cilloni; Giuseppe Saglio; Angelo Guerrasio
Journal:  Int J Hematol       Date:  2009-09-12       Impact factor: 2.490

2.  Clinical challenge: cutaneous Kaposi's sarcoma of the lower extremity.

Authors:  Erika L Johnson; Yvonne N Pierpont; Guillermo Donate; Mattew H Hiro; Rudolph J Mannari; Theodore J Strickland; Martin C Robson; Wyatt G Payne
Journal:  Int Wound J       Date:  2011-02-11       Impact factor: 3.315

3.  MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle.

Authors:  Chih-Chung Lu; Zhonghan Li; Chia-Ying Chu; Jiaying Feng; Jun Feng; Ren Sun; Tariq M Rana
Journal:  EMBO Rep       Date:  2010-09-17       Impact factor: 8.807

4.  Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.

Authors:  Jie Lu; Subhash C Verma; Masanao Murakami; Qiliang Cai; Pankaj Kumar; Bingyi Xiao; Erle S Robertson
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

5.  Prevalence of human herpesvirus 8 infection in systemic lupus erythematosus.

Authors:  Yu Sun; Shipeng Sun; Wenli Li; Bo Li; Jinming Li
Journal:  Virol J       Date:  2011-05-09       Impact factor: 4.099

Review 6.  KSHV targeted therapy: an update on inhibitors of viral lytic replication.

Authors:  Natacha Coen; Sophie Duraffour; Robert Snoeck; Graciela Andrei
Journal:  Viruses       Date:  2014-11-24       Impact factor: 5.048

Review 7.  Primary Pulmonary B-Cell Lymphoma: A Review and Update.

Authors:  Francesca Sanguedolce; Magda Zanelli; Maurizio Zizzo; Alessandra Bisagni; Alessandra Soriano; Giorgia Cocco; Andrea Palicelli; Giacomo Santandrea; Cecilia Caprera; Matteo Corsi; Giulia Cerrone; Raffaele Sciaccotta; Giovanni Martino; Linda Ricci; Francesco Sollitto; Domenico Loizzi; Stefano Ascani
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

Review 8.  Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence.

Authors:  Katherine M Feeney; Joanna L Parish
Journal:  Proc Biol Sci       Date:  2009-01-20       Impact factor: 5.349

9.  No Evidence of Human Herpesvirus 8 among Iranian Patients Infected with HIV.

Authors:  Amitis Ramezani; Elham Saboori; Kayhan Azadmanesh; Minoo Mohraz; Monireh Kazemimanesh; Afsaneh Karami; Mohammad Banifazl; Hanieh Golchehregan; Arezoo Aghakhani
Journal:  Iran J Public Health       Date:  2016-07       Impact factor: 1.429

10.  MBL2 gene polymorphisms in HHV-8 infection in people living with HIV/AIDS.

Authors:  Viviane Martha Santos de Morais; Elker Lene Santos de Lima; Georgea Gertrudes de Oliveira Mendes Cahú; Thaisa Regina Rocha Lopes; Juliana Prado Gonçales; Maria Tereza Cartaxo Muniz; Maria Rosângela Cunha Duarte Coêlho
Journal:  Retrovirology       Date:  2018-11-27       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.